Abstract Body

Background: HIV cure is limited by persistence of long lived latently infected CD4+ T cells. Latently infected cell lines are widely used in vitro to study HIV latency. We identified and tested the stability of HIV integration sites in latently infected cell lines, obtained from NIH AIDS reagent program, using a newly developed high throughput method.

Method: To determine assay sensitivity/efficiency, high molecular genomic DNA of seven latent HIV cell lines were isolated and DNA equivalent of 20 cells each were mixed with genomic DNA from a million HIV negative PBMCs. Additionally, the latently infected cell lines ACH-2, U1 and J1.1 that contain 1 or 2 integrated copies of replication competent HIV and J-Lat 8.4, 9.2, 10.6 and 15.4 cell lines that contain a single replication deficient HIV were passaged 8 times. Genomic DNA isolated after passage 0, 2, 4, 6 and 8 was enzymatically cut to random sized fragments. The fragments were end-repaired, a-tailed and a linker was ligated to the fragments which enables nested amplification. The fragments were subjected to LTR based nested PCR with barcoded nested primers and prepared for Miseq sequencing. Chromosomal alignment was determined using the Blat-UCSC Genome Browser (GRCH38/hg38).

Results: The procedure was optimized for robotic processing to increase sample throughput and decrease risk of contamination. The efficiency was 35% and detected 1 HIV integration site in 50,000 uninfected PBMCs. Latently infected cell lines infected with a deficient virus demonstrated a single integration site. In contrast, cell lines harbouring a replication competent virus demonstrated multiple distinct HIV integration sites per 150,000 cells (74 in ACH2, 42 in U1 and 93 in J1.1). J1.1, which is reported to have a single integrated copy per cell, demonstrated two major integration sites in equal frequency. Moreover, ACH-2 cells, when passaged, demonstrated a 2-fold increase in unique HIV integration sites found across the human genome.

Conclusion: Cell lines latently infected with replication competent HIV demonstrated multiple unique HIV integration sites indicating these cell lines are not clonal. Furthermore, the increase and change in sites of HIV integration observed in ACH-2 cells over time is suggestive of low level virus replication. These findings have implications for the use of latently infected cell lines as models of HIV latency and as standards for quantification of HIV integration.